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Perinatal Period and Pregnancy:
Intervals of High Risk for Chemical
Carcinogens
by Jerry M. Rice*
Experiments in rodents indicate that during the post-embryonic period of prenatal development, the
fetus is more sensitive than the adult tocertain carcinogens, by several decimalordersofmagnitude. Most
such agents are direct-acting and independent of metabolism. To other substances, often those which
require enzyme-mediated metabolic conversion to a chemically reactive derivative in order to effect
carcinogenesis, the fetus may be less vulnerable than the adult. The neonate is also more susceptible than
adults to some carcinogens, and may be more susceptible than the fetus tocertain agents. Both rodent and
primate studies indicate that gravid females are also atelevated risk for carcinogenesis, in part because of
the presence in the placenta of trophoblastic tissue which may become malignant. The contributions of
rapid growth rate, changing metabolc competence, and tissue differentiation to elevated perinatal sus-
ceptibility to carcinogens in rodents and primates are discussed, together with the implications of these
rmdings for human beings subjected to industrial or environmental exposures to such chemicals.
Introduction
The birth in Japan of many infants whose normal
physical and mental development was grotesquely
and permanently distorted by organomercurial
poisoning has clearly and tragically illustrated the
vulnerability ofhuman beings to toxic agents during
early life. The methylmercury responsible for this
disaster originated from the discharge of industrial
wastes into Minamata Bay, and demonstration of
the linkage between the industrial discharge and the
human syndrome known as Minamata Disease-a
form ofcerebral palsy-has further established that
pollution ofthe ecosystem by man can have unfore-
seen and catastrophic effects on human health (1).
Carcinogens, like methylmercury and many other
toxic agents, can also affect the very young, and
their effects are likewise irreversible and potentially
lethal. Both transplacental and early postnatal ex-
posures to many different kinds of carcinogenic
substances have been shown in rodents to result in
more severe carcinogenic effects than are elicited in
adults by comparable treatment (2-6). It has re-
cently been shown that this is not a phenomenon
limited to rodents. Transplacental carcinogenesis
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by diethylstilbestrol (DES) in the human female re-
productive tract has confirmed the significance for
human beings of prenatal exposure to carcinogens
(7). Furthermore, experimental findings in nonhu-
man primates have confirmed that also in these
animals, as in rodents, the fetus is quantitatively
more susceptible to nonhormonal, direct-acting
carcinogens than adults (8). Exposure of pregnant
women or of women of childbearing age to envi-
ronments either within or outside the workplace
where exposure to carcinogens may occur has
therefore increasingly become a matter of concern,
generally expressed exclusively in terms ofpossible
prenatal hazard to their offspring. Less extensively
documented but convincing evidence is now ac-
cumulating, however, that the pregnant female is
herself at higher risk to at least some carcinogens
than nonpregnant adults of comparable age. Ac-
cordingly the fetus, the infant, and the pregnant
female are all reviewed in this report as individuals
in transitory states of heightened susceptibility to
carcinogenesis.
Transplacental Carcinogenesis
Organic compounds of low molecular weight
which are nonionic readily cross the placenta, and
those which are carcinogenic can induce inapparent
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The potential neoplastic cells which result may only
proliferate to generate grossly apparent tumors long
afterbirth. Transplacental carcinogenesis in rodents
has been extensively reviewed and summarized
(2-6), and only the principal conclusions from these
summaries will be given here.
As many chemical carcinogens require enzyme-
mediated metabolism to a chemically reactive de-
rivative, or ultimate carcinogen, in order to effect
neoplastic transformation (9), and since the enzyme
systems required for these transformations are
present at low levels or not at all in fetal rodent
tissues until shortly before birth (10), the efficiency
of a compound as a transplacental carcinogen will
be largely determined by whether or not it is depen-
dent on metabolism. The most effective transpla-
cental carcinogens are enzyme-independent, i.e.,
direct-acting, such as the alkylating agents (alkylni-
trosamides, alkyl alkylsulfonates, etc.). For an
enzyme-dependent agent to be a transplacental car-
cinogen, one of two conditions must be met: the
ultimate carcinogenic metabolite must be formed in
maternal or placental tissues and must be suffi-
ciently stable to reach the fetus by subsequent pas-
sage through maternal and fetal circulations; or it
must be formed within the fetal target tissues.
Agents which are potent carcinogens in adults, but
which are poorly metabolized in fetal tissues and
yield highly unstable (short-lived) reactive metabo-
lites, are generally less effective transplacentally,
e.g., dimethylnitrosamine (11).
In rodents, the fetus is susceptible to chemical
carcinogens, but the embryo generally is not. In the
rat and mouse, major organ systems become vul-
nerable to direct-acting carcinogens after the de-
finitive organ rudiments have formed, at approxi-
mately day 11 of gestation, and susceptibility in-
creases rapidly thereafter, becoming maximal a few
days prior to birth. At the time ofmaximal suscepti-
bility, vulnerable organ systems may be as much as
two decimal orders of magnitude more susceptible
in the fetus than in the adult. In the rat for example,
a single intravenous exposure to ethylnitrosourea
(ENU) at a dosage of 160 mg/kg body weight pro-
duced tumors of the nervous system in 50% of
treated adults; the offspring of rats given ENU on
day 15 of gestation developed a comparable inci-
dence ofneurogenic tumors at a dose (to the dams)
ofonly 3.2 mg/kg (12). To agents dependent on fetal
oxidative enzyme systems, susceptibility may be
confined to the last few days before birth, as only
then are the necessary enzymes present in signifi-
cant quantity (11). Many enzyme-dependent car-
cinogens are nonetheless extremely effective trans-
placentally, suggesting an important role for mater-
nal metabolism in the activation of these com-
pounds.
A given carcinogen will usually induce tumors of
different organ systems in different species. This is
true for both direct-acting and enzyme-dependent
carcinogens. ENU, for example, under comparable
conditions of transplacental exposure, induces al-
most exclusively tumors of the nervous system in
rats, but in mice yields epithelial tumors, principally
of the lungs and liver. The overwhelming majority
of transplacentally induced tumors in rodents, ir-
respective of the organ system in which they de-
velop, are of adult morphology, although the car-
cinogenic exposure which initiated their develop-
ment occurred while morphogenetic differentiation
was still in progress. On the basis of morphology,
therefore, it is not possible in experimental animal
systems to distinguish tumors induced by prenatal
exposure to a carcinogen from those originating
after birth.
No agent is known which is carcinogenic exclu-
sively during prenatal life in all systems. The liter-
ature on transplacental carcinogenesis has de-
veloped by testing compounds known from studies
in adults to be carcinogenic in the test species. The
wide variety of compounds already shown to be
carcinogenic transplacentally suggests that most
carcinogens will to some extent affect the offspring
when given during pregnancy.
Recent studies in nonhuman primates have con-
firmed the greater susceptibility of the fetus to a
representative direct-acting carcinogen, ENU (8).
An important difference is that in the patas monkey
(Erythrocebus patas), and presumably in other pri-
mates, fetal susceptibility is maximal during the first
third of the gestation period, corresponding to the
first trimester of human pregnancy. In fact, the
stages ofdevelopment ofthe mouse and rat between
days 11 and 20 of gestation and of the monkey be-
tween days 30 and 60, are roughly comparable. The
practical consequence is however, that if human
prenatal susceptibility is like that of the lower pri-
mate, the human fetus may be most susceptible to at
least some transplacental carcinogens before the
mother may know she is pregnant.
Carcinogenesis During Early
Postnatal Life
The neonatal mouse and to a lesser extent, the
neonatal rat and occasionally other species, have
also been shown to exhibit greater ssusceptibility
than adults to many, but not all, chemical carcino-
gens. Studies on neonates have been carried out
chiefly in the context ofbioassay of suspected car-
cinogens, and the results have been critically re-
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ceptibility ofthe newborn is very pronounced, as in
the case ofaflatoxin B1 in the infant mouse (14). The
results in rodents have been sufficiently striking
that subsequent investigators studying primates
have introduced neonatal exposure as a standard
protocol to evaluate nonhuman primate responses
to a wide variety ofcarcinogens (15). The available
evidence is sufficiently convincing to warrant con-
sideration ofearly postnatal life as a period of gen-
erally enhanced susceptibility.
Enhanced Susceptibility of Adult
Females During Pregnancy
The possibility of a transitory state of increased
susceptibility to carcinogens during pregnancy has
not been systematically studied, and individual re-
ports in the literature have attracted little notice.
Ivankovic (16) reported that rats given ENU during
pregnancy frequently died subsequently to malig-
nant tumors ofthe ovaries, uterus, and vagina, and
that these sites were rarely involved in nonpregnant
rats given this carcinogen. Alexandrov (17) reported
similar findings in pregnant rats given either ENU
or its methyl homolog, and observed mammary
tumors in addition to those ofthe reproductive sys-
tem. While a few of the uterine tumors were of
Schwann cell origin and can be interpreted as a
manifestation of the pronounced susceptibility of
the rat nervous system to alkylnitrosoureas, the
great majority of neoplasms in the uterus and all
those of ovary, mammary glands, and vagina were
of epithelial or mesenchymal origin. As these are
hormone-responsive tissues and the female endo-
crine system undergoes major functional changes
during pregnancy, it is reasonable to infer a hor-
monal component in the pathogenesis of these
tumors.
Recent observations in this laboratory in the
course of studies on transplacental carcinogenesis
in the patas monkey indicate both a confirmation of
heightened maternal susceptibility in this non-
human primate and an additional dimension to car-
cinogenic risk during pregnancy. The latter consists
of highly malignant tumors apparently of tropho-
blastic origin which are rapidly fatal. A typical case
ofthe five so far observed is illustrated in Figures I
and 2. The animal illustrated had received ENU
during the early months of pregnancy, delivered a
live infant 17 weeks after the first injection, and died
suddenly and unexpectedly 5 weeks later from ex-
sanguinating pulmonary hemorrhage. No obvious
primary tumor was found, but multiple tumor
nodules were apparent in several of the viscera,
especially the lungs. Tumor cells in these cases
have often been found microscopically in the
uterine endometrial stroma and myometrium. The
disease resembles human choriocarcinoma both
clinically and histologically, and is one of the most
rapidly progressive chemically induced neoplasms
ever reported in a primate. No similar tumors have
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FIGURE 1. Low-power view of one of many pulmonary metastases in a female patas monkey which died of sudden exsanguinating
pulmonary hemorrhage 5 weeks post partum. The animal had received ENU during pregnancy. Masses of tumor cells line
ill-defined spaces divided by connective tissue septae. H & E, x80.
April 1979 25FIGURE 2. Higher magnification illustrates detail oflarge cells resembling cytotrophoblast, some in mitosis. H & E, x430.
been seen in nongravid females given the same
regimen ofENU for the same or longer periods and
observed for much longer times.
The evidence from both rat and primate studies,
although limited, thus suggests that the pregnant
female is at higher risk to at least certain carcino-
gens than nongravid females or males of compara-
ble age.
Discussion
The empirical nature of current knowledge of
perinatal susceptibility to carcinogenesis dictates
caution in extrapolating beyond specific data, espe-
cially between species. The reasons for increased
susceptibility during early life are not clear, beyond
the fact that rapidly proliferating tissues are intrin-
sically at higher risk to carcinogenesis than those
with lower rates of cell division. The fact that em-
pirical observations ofheightened perinatal suscep-
tibility have been made not only in several rodent
species, but also in primates, however, justifies the
inference that humans must also be considered
especially vulnerable to carcinogens during early
life, both before and after birth.
There are no data to support the inference that
pregnant human beings also resemble lower animals
in being at higher risk to chemical carcinogens.
Even though the experimental data are less well
established for this hypothesis, the consequences
are potentially important enough to warrant consid-
eration, and re-emphasize the importance ofrecog-
nizing and avoiding exposure to carcinogens during
pregnancy.
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